本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×

产品中心Cell Resources

联系我们CONTACT US

  • 人甲状腺滤泡上皮细胞完全培养基
  • 人甲状腺滤泡上皮细胞完全培养基
  • 人甲状腺滤泡上皮细胞完全培养基
  • 人甲状腺滤泡上皮细胞完全培养基

人甲状腺滤泡上皮细胞完全培养基

货号:CM-H023

价格:¥6002680

规格:
100mL
  • 100mL
  • 125mL×4
数量: - +
  • 人甲状腺滤泡上皮细胞完全培养基
  • 人甲状腺滤泡上皮细胞完全培养基
  • 人甲状腺滤泡上皮细胞完全培养基
  • 人甲状腺滤泡上皮细胞完全培养基
产品概述

产品简介

人甲状腺滤泡上皮细胞完全培养基由普诺赛技术团队精心优化,经过长期测试,本产品可保持人甲状腺滤泡上皮细胞最佳的生长状态。本产品中已包含人甲状腺滤泡上皮细胞生长所需的各种成分,无需添加任何成分,可直接用于人甲状腺滤泡上皮细胞的体外培养。本产品仅供进一步科研使用,不得用于诊断、治疗、临床、家庭及其它用途。

产品说明

产品形态 液体
产品浓度
产品规格 100mL/125mL×4
细菌检测 阴性
真菌检测 阴性
支原体检测 阴性
细胞生长实验 细胞生长良好,形态正常
内毒素含量(EU/mL) ≤3
储存条件 2~8℃,避光储存
运输条件 冰袋冷藏运输
有效期 3个月

注意事项

1. 使用产品时应注意无菌操作,避免污染。
2. 本产品为全营养组分的培养基,如无特别需要不用额外再添加血清和双抗,可以直接使用。
3. 为保持本产品的最佳使用效果,不宜将其长时间放置于室温或较高的温度环境中。
4. 所有产品请于保质期内使用,超出保质期,必须放弃使用。
5. 本产品只供进一步科研使用,不可应用于临床等其他方面。
参考文献
文献列表
  • Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer (2023-03-01)

    作者:Xiaoli Liu:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun, Jilin, China. ; Chunhai Zhang:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun, Jilin, China. ; Xiaomiao Wang:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun, Jilin, China. ; Can Cui:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun, Jilin, China. ; Hanwen Cui:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun, Jilin, China. ; Baishu Zhu:1.Division of Thyroid Surgery, China-Japan Union Hospita

    期刊:Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer

    DOI:10.1530/ERC-22-0221

    影响因子 :3.9

    引用产品: 人甲状腺滤泡上皮细胞 ,  人甲状腺滤泡上皮细胞完全培养基

  • circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8) (2006-01-20)

    作者:Yu Mao:1.Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China. ; Yajie Huo:1.Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China. ; Jing Li:1.Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China. ; Yanli Zhao:1.Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China. ; Yuan Wang:1.Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China. ; Ling Sun:1.Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China. ; Zhiqiang Kang:1.Department of Endocrinology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China. ;

    期刊:circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8)

    DOI:10.1507/endocrj.EJ21-0072

    影响因子 :2.9

    引用产品: 人甲状腺滤泡上皮细胞完全培养基

  • miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer (2001-00-20)

    作者:Xiang-da Fan:1.Department of Head and Neck Oncology, Gansu Provincial Cancer Hospital and Gansu Provincial Academic Institute for Medical Research, Lanzhou 730050, China. ; Yan Luo:1.Department of Pathology, Gansu Provincial Cancer Hospital and Gansu Provincial Academic Institute for Medical Research, Lanzhou 730050, China. ; Jun Wang:1.Department of Head and Neck Oncology, Gansu Provincial Cancer Hospital and Gansu Provincial Academic Institute for Medical Research, Lanzhou 730050, China. ; Ning An:1.Department of Head and Neck Oncology, Gansu Provincial Cancer Hospital and Gansu Provincial Academic Institute for Medical Research, Lanzhou 730050, China. ;

    期刊:miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer

    DOI:10.1042/BSR20193158

    影响因子 :4.0

    引用产品: 人甲状腺滤泡上皮细胞完全培养基

  • miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo signaling in Thyroid Cancer (2011-09-20)

    作者:Xiaoli Liu:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun City, Jilin Province, 130033, China. ; Yantao Fu:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun City, Jilin Province, 130033, China. ; Guang Zhang:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun City, Jilin Province, 130033, China. ; Daqi Zhang:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun City, Jilin Province, 130033, China. ; Nan Liang:1.Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun C

    期刊:miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo signaling in Thyroid Cancer

    DOI:10.1016/j.omto.2019.10.008

    影响因子 :5.7

    引用产品: 人甲状腺滤泡上皮细胞完全培养基 ,  人甲状腺滤泡上皮细胞 ,  TT 细胞

  • LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer (2004-09-20)

    作者:Xiaoli Liu:1.Division of Thyroid Surgery, Jilin Provincial Key Laboratory of Surgical Translational Medicine, China-Japan Union Hospital of Jilin University, Changchun, China. ; Qingfeng Fu:1.Division of Thyroid Surgery, Jilin Provincial Key Laboratory of Surgical Translational Medicine, China-Japan Union Hospital of Jilin University, Changchun, China. ; Shijie Li:1.Division of Thyroid Surgery, Jilin Provincial Key Laboratory of Surgical Translational Medicine, China-Japan Union Hospital of Jilin University, Changchun, China. ; Nan Liang:1.Division of Thyroid Surgery, Jilin Provincial Key Laboratory of Surgical Translational Medicine, China-Japan Union Hospital of Jilin University, Changchun, China. ; Fang Li:1.Division of Thyroid Surgery, Jilin Provincial Key Laboratory of Surgical Translational Medicine, China-Japan Union Hospital of Jilin University, Changchun, China. ; Changlin Li:1.Division of Thyroid Surgery, Jilin Provincial Key Laboratory of Surgical Translational Medicine

    期刊:LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer

    DOI:10.3389/fendo.2019.00207

    影响因子 :5.2

    引用产品: 人甲状腺滤泡上皮细胞 ,  人甲状腺滤泡上皮细胞完全培养基 ,  TT 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号